Smooth muscle cells of human intracranial aneurysms assume phenotypic features similar to those of the atherosclerotic plaque.
暂无分享,去创建一个
Philippe Bijlenga | Giulio Gabbiani | Enikö Kövari | Karl Schaller | K. Schaller | P. Bijlenga | D. Rüfenacht | G. Gabbiani | E. Kövari | K. Burkhardt | M. Bochaton-Piallat | Daniel A Rüfenacht | D. S. M. Ruíz | Marie-Luce Bochaton-Piallat | G. Pizzolato | Matteo Coen | Karim Burkhardt | Diego San Millán Ruíz | Giampaolo Pizzolato | M. Coen
[1] Y. Ushio,et al. Differential distribution and expressions of collagens in the cerebral aneurysmal wall , 1997, Acta Neuropathologica.
[2] I. Sibon,et al. Association between semicarbazide-sensitive amine oxidase, a regulator of the glucose transporter, and elastic lamellae thinning during experimental cerebral aneurysm development: laboratory investigation. , 2008, Journal of neurosurgery.
[3] Paula Clancy,et al. Association Between Osteopontin and Human Abdominal Aortic Aneurysm , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[4] M. Bacchetta,et al. Intimal Smooth Muscle Cells of Porcine and Human Coronary Artery Express S100A4, a Marker of the Rhomboid Phenotype In Vitro , 2007, Circulation research.
[5] Mohammad Saleem,et al. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9 , 2006, Proceedings of the National Academy of Sciences.
[6] D. Helfman,et al. The metastasis associated protein S100A4: role in tumour progression and metastasis , 2005, British Journal of Cancer.
[7] M. Andréani,et al. Semicarbazide‐Sensitive Amine Oxidase in Vascular Smooth Muscle Cells: Differentiation‐Dependent Expression and Role in Glucose Uptake , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[8] S. P. Walton,et al. Smooth muscle phenotypic modulation is an early event in aortic aneurysms. , 2009, The Journal of thoracic and cardiovascular surgery.
[9] M. Klapholz,et al. Osteopontin in Cardiovascular Disease: A Potential Therapeutic Target , 2010, Cardiology in review.
[10] I. Awad,et al. Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. , 1996, Neurosurgery.
[11] R. Virmani,et al. Phenotypic Modulation of Intima and Media Smooth Muscle Cells in Fatal Cases of Coronary Artery Lesion , 2005 .
[12] M. Günel,et al. Expression of Structural Proteins and Angiogenic Factors in Normal Arterial and Unruptured and Ruptured Aneurysm Walls , 2005, Neurosurgery.
[13] D. Milewicz,et al. TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections. , 2010, Cardiovascular research.
[14] S. Hirota,et al. Alpha actin isoforms expression in human and rat adult cardiac conduction system. , 2009, Differentiation; research in biological diversity.
[15] Julie H. Campbell,et al. Extracellular Matrix‐Smooth Muscle Phenotype Modulation by Macrophages a , 1990, Annals of the New York Academy of Sciences.
[16] J. Thyberg,et al. Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: an electron-microscopic and stereological study , 1995, Cell and Tissue Research.
[17] G. V. van Eys,et al. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells , 1996, The Journal of cell biology.
[18] T. Sano,et al. Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls , 2000, Acta Neuropathologica.
[19] M. Savolainen,et al. Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic aneurysms. , 2013, The Journal of thoracic and cardiovascular surgery.
[20] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[21] M. Taneda,et al. Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. , 1999, Stroke.
[22] S. Clément,et al. β- and γ-cytoplasmic actins display distinct distribution and functional diversity , 2009, Journal of Cell Science.
[23] Aman B Patel,et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association , 1994, Stroke.
[24] G. Mælandsmo,et al. Osteopontin—An important downstream effector of S100A4‐mediated invasion and metastasis , 2011, International journal of cancer.
[25] M. Piechota,et al. Gene Expression Profiles in Human Ruptured and Unruptured Intracranial Aneurysms: What Is the Role of Inflammation? , 2010, Stroke.
[26] A. Algra,et al. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis , 2011, The Lancet Neurology.
[27] G. Gabbiani,et al. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation , 1986, The Journal of cell biology.
[28] T. Kiehl,et al. Intracranial aneurysms: from vessel wall pathology to therapeutic approach , 2011, Nature Reviews Neurology.
[29] S. Mishra,et al. S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence , 2011, Cancer and Metastasis Reviews.
[30] M. Grigorian,et al. Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity , 2004, Oncogene.
[31] O. T. Odegaard,et al. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. , 1999, Cancer research.
[32] A. Chiavegato,et al. Molecular and cellular phenotypes and their regulation in smooth muscle. , 1999, Reviews of physiology, biochemistry and pharmacology.
[33] W. Koch,et al. Biology of Intracranial Aneurysms: Role of Inflammation , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[34] G. Owens,et al. Regulation of differentiation of vascular smooth muscle cells. , 1995, Physiological reviews.
[35] P. Doevendans,et al. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity , 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.